secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001104659-24-070114
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise shareholders elect directors, ratify KPMG, approve officer exculpation charter amendment
--------------------------------------------------------------------------------

- Elected Class III directors Thompson, Koch, and Fox with 65M–75M shares For vs 6.9M–17.3M Against; broker non-votes 8.2M.
- Ratified KPMG LLP as independent auditor for FY 2024: 90.5M For, 4K Against, 35K Abstain.
- Approved certificate amendment to limit officer liability per Delaware law: 81.4M For, 938K Against, 1.4K Abstain; broker non-votes 8.2M.
- Amendment to Article IX of the certificate of incorporation was filed on June 10, 2024, effective upon filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465924070114/0001104659-24-070114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465924070114/tm2416817d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-070114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer